, Tracking Stock Market Picks
Enter Symbol:
Home Diagnostics, Inc. (HDIX) [hlAlert]

down 12.23 %

Home Diagnostics, Inc. (HDIX) rated Buy with price target $14 by Wasserman & Associates

Posted on: Thursday,  Oct 23, 2008  11:25 AM ET by Wasserman & Associates

Wasserman & Associates rated Buy Home Diagnostics, Inc. (NASDAQ: HDIX) on 10/23/2008, when the stock price was $6.95.
Since then, Home Diagnostics, Inc. has lost 12.23% as of 03/15/2010's recent price of $6.10.
If you would have followed this Wasserman & Associates's recommendation on HDIX, you would have lost 12.23% of your investment in 508 days.

Home Diagnostics, Inc. (HDI), develops, manufactures and markets of blood glucose monitoring systems and disposable supplies for people with diabetes worldwide. HDI partners with food and drug retailers, mass merchandisers, distributors, mail service providers and third-party payors in the United States and internationally to deliver its products to people with diabetes. The Company markets its products under its own brands, including TRUEresult, TRUE2go, TRUEtest, TRUEtrack, Sidekick, TRUEread and Prestige IQ, and under a co-branded format through which HDI adds its customers? store brand name to its brand name products. HDI also markets its products to managed care organizations including health plans and pharmacy benefits managers (PBMs) for inclusion on formularies, which are lists of approved products from which the insured or member and their physicians can choose, and granting of preferred product status by health plans.

Wasserman & Associates Inc does business in Securities Brokers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2008 11:25 AM Buy
6.95 14.00
as of 12/24/2008
1 Week down  -6.48 %
1 Month up  14.98 %
3 Months up  18.91 %
1 YTD up  18.91 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy